Australia's largest stock trading and investment forum Australia's #1 stock forum

They definitely looking to partner up, wont be going it alone....

First 1156 Last

Share
Profile

Follow
Rajenp5

2,329 Posts.

17

19/02/24

12:23

Post #: 72482292
Share

Originally posted by reggie78: ↑

HI Rajenp5,

I have just had a look at post shared by Avarice67 re current trails and end dates.

These are big trials so not sure if phase 3's would need to be big also.

Phase 3 wouldn't be cheap, US$300m

So close to US$1bn if they want to go all x 3 alone.

x 3 positive phase 2's would change the share price significantly, perhaps would need evaluate then based on price.

Would have to think x 3 phase 2 complete assets would be worth US $1.5-$2bn each?

There would be plenty of interest from other big pharmas to TO at US$6bn or alternativly partner or licence as a option also.

Expand

They definitely looking to partner up, wont be going it alone. Will be going cap in hand is my fear...see stelfonta. Wonder how stelfonta would have done if Virbac owned it.

Still wIting for wound healing progress. Why this hasnt been given more focus is odd. Guess not as glam as cancer..
Upvote

Reply

There are more pages in this discussion • 35 more messages in this thread...

First 1156 Last

SPONSORED BY